Comet assay in human biomonitoring studies: Reliability, validation, and applications

The comet assay (single‐cell gel electrophoresis), which measures DNA strand breaks at the level of single cells, is very easily applied to human lymphocytes, and therefore lends itself to human biomonitoring studies. For the examination of DNA base oxidation (a specific marker of oxidative damage), the assay is modified by including a stage at which the DNA is incubated with a suitable lesion‐specific endonuclease. Here we report on the reliability and reproducibility of this approach, from the level of comparing results from duplicate gels prepared from the same sample of cells, up to an assessment of the natural intra‐ and interindividual variability in lymphocyte DNA damage measured in groups of normal, healthy human volunteers. We applied the assay in investigations of human disease and occupational exposure of factory workers. Environ. Mol. Mutagen. 30:139–146, 1997. © 1997 Wiley‐Liss, Inc.

[1]  D. Mitchell,et al.  UV‐sensitive rodent mutant cell lines of complementation groups 6 and 8 differ phenotypically from their human counterparts , 1997, Environmental and molecular mutagenesis.

[2]  A. Collins,et al.  The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. , 1995, Mutation research.

[3]  M. Green,et al.  The single cell gel electrophoresis assay (comet assay): a European review. , 1993, Mutation research.

[4]  A. Collins,et al.  Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. , 1996, Cancer research.

[5]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[6]  P. Olive,et al.  The comet assay: a comprehensive review. , 1995, Mutation research.

[7]  M. J. R. Healy.  GLIM: An Introduction , 1988 .

[8]  K. Steenland,et al.  Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[10]  A. Collins,et al.  Oxidative damage to DNA: do we have a reliable biomarker? , 1996, Environmental health perspectives.

[11]  A. Collins,et al.  The influence of smoking and diet on the hypoxanthine phosphoribosyltransferase (hprt) mutant frequency in circulating T lymphocytes from a normal human population. , 1995, Mutation research.